The investigators propose a cluster-randomized clinical trial to determine whether an
intensive, targeted azithromycin distribution strategy is effective for elimination of
trachoma at the kebele level compared to the World Health Organization (WHO) recommendation
of annual azithromycin distribution.
Phase:
Phase 4
Details
Lead Sponsor:
University of California, San Francisco
Collaborators:
Bahir Dar University Eyu-Ethiopia National Eye Institute (NEI) The Carter Center